

[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
[ Fri, Apr 26th 2024
] - WOPRAI
Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $125 on, Apr 26th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $125 on, Apr 26th, 2024.
Andrew has made no other calls on BPMC in the last 4 months.
There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024
These are the ratings of the 2 analyists that currently disagree with Andrew
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Wednesday, April 10th, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024
Contributing Sources